•
VO
VOR
Vor Biopharma Inc. Common Stock
yahooBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
--
Price Chart
Market Cap
396.14M
Volume
950.40K
52W High
$65.80
52W Low
$2.62
Open
$0.00
Prev Close
$17.60
Day Range
0.00 - 0.00
About Vor Biopharma Inc. Common Stock
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
Latest News
Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock
GlobeNewswire Inc.•Nov 11
Telitacicept Achieved Primary Endpoint of Reducing Proteinuria in Stage A of a Phase 3 Clinical Study for IgA Nephropathy in China
GlobeNewswire Inc.•Nov 8
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.•Oct 31
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.•Aug 18
Vor Bio Announces $175 Million Private Placement
GlobeNewswire Inc.•Jun 25
Vor Bio Appoints Life Sciences and Technology Investor and Entrepreneur, Mr. Erez Kalir to its Board of Directors
GlobeNewswire Inc.•Jan 8
Vor Bio Announces $55.6 Million Private Placement
GlobeNewswire Inc.•Dec 27
Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer
GlobeNewswire Inc.•Sep 30